Menu
Not yet recruiting NCT07596368

THE EFFECT OF MOTIVATIONAL INTERVIEWING ON MENOPAUSE MYTHS AND POSTTRAUMATIC GROWTH IN POSTMENOPAUSAL WOMEN:RANDOMIZED CONTROLLED STUDY

No phase Interventional Menopause Postmenopausal State

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Motivational interviewing.
Who it may be relevant to
Registry conditions: Menopause, Postmenopausal State. Basic parameters: No limits · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This randomized controlled study aims to evaluate the effect of motivational interviewing on menopause myths and posttraumatic growth in postmenopausal women. Participants will be randomly assigned to an intervention group receiving four weekly motivational interviewing sessions or a control group receiving usual care. Outcomes will be assessed before and after the intervention using validated scales.

Detailed description

Menopause is a biological transition that may affect women physically, psychologically, and socially. Misconceptions regarding menopause may negatively influence adaptation to this period, while positive coping may support posttraumatic growth.

Motivational interviewing is a client-centered counseling approach designed to strengthen intrinsic motivation and promote positive behavioral change. This randomized controlled trial aims to determine the effect of motivational interviewing on menopause myths and posttraumatic growth in postmenopausal women.

The study will be conducted in Family Health Centers in Gaziantep, Turkey, with 96 postmenopausal women randomly assigned to intervention and control groups. The intervention group will receive four weekly face-to-face motivational interviewing sessions lasting 30-45 minutes. The control group will receive usual care without intervention.

Data will be collected at baseline and after intervention using the Menopause Myths Scale and the Posttraumatic Growth Scale.

Interventions

  • Behavioral Motivational interviewing
    The researcher provided training on motivational interviewing techniques to be applied to the experimental group prior to the intervention. Women will be informed about the research, and those wishing to participate will be given a voluntary information form to read, and their verbal and written consent will be obtained. The client will be informed about the duration, number, and timing of the interviews before the start of the MG sessions. Each motivational interview session with the women in t

Primary outcome measures

  • MENOPAUSE MYTHS SCALE [Time frame: At the beginning and at the end of the 4-week intervention period]
Secondary outcome measures (1)
  • Post-Traumatic Growth Scale [Time frame: At the beginning and at the end of the 4-week intervention period]

Eligibility criteria

Inclusion criteria

  • Women who have had their last menstrual period between 12 and 36 months ago,
  • are literate,
  • can read and write in Turkish,
  • do not have any problems that may hinder communication, and
  • do not have any diagnosed psychiatric illness will be included in the study.

Exclusion criteria

  • Those receiving HRT treatment,
  • Those whose last menstrual period was 36 months or more ago,
  • Women receiving oncology treatment.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07596368 · 860686

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗